Maker Of Antipsychotic Drug Tells Federal Circuit Patent Is Infringed

Mealey's (January 30, 2018, 12:27 PM EST) -- WASHINGTON, D.C. — In a Jan. 26 cross-appellant brief Forest Laboratories LLC argued that although a Delaware federal judge properly determined that two claims of the patented atypical antipsychotic drug Saphris...
To view the full article, register now.